Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evolving Epidemiology and Emerging Antifungal Resistance in Vulvovaginal Candidosis: Evidence from a Five-Year Survey.

Pathogens (Basel, Switzerland)·2026

Same author

Large Language Models for Clinical Narrative Processing: Methods, Applications, and Challenges.

Methods and protocols·2026

Same author

Managing Bone Infections Beyond Systemic Antibiotics: A Scoping Review.

Pathogens (Basel, Switzerland)·2026

Same author

Clinical, Demographic, and Virological Predictors of Hospital Admission in Patients with Acute Viral Respiratory Infections: A Retrospective Observational Study.

Viruses·2026

Same author

Prognostic Value of SIRS, SOFA, qSOFA, and LqSOFA in Emergency Department Sepsis Patients and Correlation of Cytokine Patterns With In-Hospital Mortality.

Journal of clinical medicine research·2026

Same author

Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2026

Search research articles

Related Experiment Video

Updated: May 30, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

An update on newer antifungals.

Karolina Akinosoglou^1,2, Despoina Papageorgiou², Charalambos Gogos²

¹Department of Internal Medicine and Infectious Diseases, University General Hospital of Patras, Rio, Greece.

Expert Review of Anti-Infective Therapy

|January 30, 2025

Summary

New antifungal agents show promise for treating invasive fungal infections, offering better drug properties and activity. Further clinical data is needed to integrate these novel treatments into standard patient care.

Keywords:

Fungal infections fosmanogepix ibrexafungerp novel antifungals olorofim opelconazole oteseconazole rezafungin

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

Related Experiment Videos

Last Updated: May 30, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance

Published on: December 28, 2017

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms

Published on: October 21, 2010

Area of Science:

Medical Mycology
Infectious Diseases
Pharmacology

Background:

Fungal infections pose a major global health challenge, causing millions of deaths annually.
Rising antifungal resistance and limitations of current therapies necessitate the development of new treatments.
Evolving fungal epidemiology underscores the urgent need for innovative antifungal strategies.

Purpose of the Study:

To review the latest advancements in novel antifungal agents.
To highlight key findings from clinical trials of new antifungal drugs.
To assess the potential of new agents in managing invasive fungal infections.

Main Methods:

Comprehensive literature search for recent clinical trials on antifungal agents.
Analysis of data on efficacy, safety, and pharmacokinetic profiles.
Evaluation of evidence for improved bioavailability, drug interactions, and spectrum of activity.

Main Results:

Novel antifungal agents demonstrate potential for improved clinical outcomes.
Key trial evidence suggests enhanced pharmacokinetic properties and reduced adverse events.
New drugs offer broader spectrum activity against resistant fungal strains.

Conclusions:

Emerging antifungal agents represent a promising therapeutic avenue for invasive fungal infections.
Further clinical data is essential to establish the role of these agents in routine practice.
Continued research is crucial for optimizing the management of challenging fungal infections.